NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ:

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
281
NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation at Upcoming Emerging Growth Conference

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, will be featured in this week’s Emerging Growth Conference. The conference is slated for June 12–13, 2024. According to the announcement, InMed Pharmaceuticals CEO Eric A. Adams will be presenting at the two-day event. During his presentation, Adams will provide a corporate overview of the company; the presentation will also include a Q&A session. Adams’ presentation is scheduled to begin at 1:45 p.m. EDT on June 13. An archived replay of the presentation will be available on the InMed Pharmaceuticals website. The Emerging Growth conference is designed to provide an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office and in a time-efficient manner.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://nnw.fm/INM

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

InMed Pharmaceuticals, Inc. (INM) Stock Research Links

INM Board Company Profile Buy Rating Time & Sales News Filings Financials